The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
On October 6, 2026, Caribou Biosciences, Inc. filed an 8-K with the SEC revealing that its Board of Directors approved a ...
Pardes Biosciences is a busted biopharma that is exploring strategic alternatives and trades at a wide 30% discount to its net cash. The company recently received a buyout proposal from its major ...
SAN DIEGO, CALIFORNIA / ACCESS Newswire / February 25, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative ...
Inhibrx Biosciences, Inc. is a high-risk, catalyst-driven biotech, with valuation hinging on the clinical success of ozekibart and INBRX-106. INBX reported an FY25 net loss of $140.1 million, ...
The Billionaire Bioscience Code is a wealth manifestation program that improves the financial portfolio of any user. The program includes three bonuses; all materials are instantly available after ...
During the last three months, 5 analysts shared their evaluations of Caribou Biosciences (NASDAQ:CRBU), revealing diverse outlooks from bullish to bearish. The table below provides a concise overview ...
Ensysce Biosciences (NASDAQ: ENSC) shares are up on Friday as the company has initiated a review of strategic alternatives aimed at enhancing shareholder value. The company on Wednesday announced that ...
Ratings for Arcus Biosciences (NYSE:RCUS) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results